<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03670797</url>
  </required_header>
  <id_info>
    <org_study_id>Diabetes-Oral Alterations</org_study_id>
    <nct_id>NCT03670797</nct_id>
  </id_info>
  <brief_title>Prevalence Of Oral Mucosal Alterations In Diabetes Mellitus Type2</brief_title>
  <official_title>Prevalence Of Oral Mucosal Alterations In a Sample of Egyptian Patients With Diabetes Mellitus Type2: A Hospital Based Cross Sectional Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Alaa Mahmoud abd El kader</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Cairo University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Cairo University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      There are severe deficiency of database concerning the oral health status in Egyptian&#xD;
      patients with Diabetes type 2. Our aim in the present study is to study the prevalence of&#xD;
      oral mucosal alterations in type 2 DM patients and the effect of hyperglycemia on these&#xD;
      alterations in controlled and uncontrolled patients to increase their awareness and minimize&#xD;
      all the possible risk factors,to achieve a proper management for all oral problems.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The study will be held in the Endocrine clinic at El Kasr Al-Ainy Cairo University Hospital&#xD;
      for patients with diabetes mellitus type2. The data collected through the questionnaire will&#xD;
      be obtained through an interview between the investigator and the patient.Clinical&#xD;
      examination will be performed for the oral cavity.Blood sample will be withdrawn from each&#xD;
      participant and collected in the clinical pathology lab in El kasr Al Ainy to measure the&#xD;
      glycosylated hemoglobin concentration.The salivary gland function will be determined through&#xD;
      a small questionnaire and clinical examination of the patient.&#xD;
&#xD;
      Selection bias: will be minimized by enrolling the participants in the study in a consecutive&#xD;
      order of the entering the clinic.&#xD;
&#xD;
      Non-respondent bias: will be minimized by explaining to the participants the aim of the study&#xD;
      and their importance and role in the study.&#xD;
&#xD;
      Incomplete records: will be excluded from statistical analysis with reporting the cause of&#xD;
      not completing the record.&#xD;
&#xD;
      Sample size estimation:&#xD;
&#xD;
      Based on the previous papers by AL-Maweri,et al ,2013, the prevalence of oral mucosal&#xD;
      alterations in diabetic patients 45.1%.Using a precision of 5, a design effect set at 1 with&#xD;
      95% CI (confidence interval), a total sample size of 381 will be sufficient. The sample size&#xD;
      was calculated by Epi info.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">December 25, 2018</start_date>
  <completion_date type="Actual">August 20, 2019</completion_date>
  <primary_completion_date type="Actual">July 30, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Ecologic or Community</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Oral mucosal alterations</measure>
    <time_frame>10 min</time_frame>
    <description>Clinical examination according to WHO guidelines by Dichotomous outcome (Yes/No).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Periodontal condition</measure>
    <time_frame>10 min</time_frame>
    <description>Basic periodontal examination by Continuous outcome (Score codes).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Salivary glands function</measure>
    <time_frame>10 min</time_frame>
    <description>Clinical oral dryness examination and Self estimated questionnaire by Dichotomous outcome (Yes/No).</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">500</enrollment>
  <condition>Oral Disease</condition>
  <condition>Diabetes</condition>
  <arm_group>
    <arm_group_label>controlled diabetic patients</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>uncontrolled diabetic patients</arm_group_label>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        A convenience sample of adult patients diagnosed with diabetes type 2 attending at the&#xD;
        Endocrine clinic at El Kasr Al-Ainy Cairo University Hospital will be enrolled in the study&#xD;
        in a consecutive order.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Adult patients&#xD;
&#xD;
          2. Patients &gt;25years old&#xD;
&#xD;
          3. Patients diagnosed with diabetes type 2.&#xD;
&#xD;
          4. Egyptian patients.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. females diagnosed with gestational diabetes.&#xD;
&#xD;
          2. Patients not physically able to participate in survey or clinical oral examination.&#xD;
&#xD;
          3. Patients with other systemic diseases which may cause oral manifestation as liver&#xD;
             disorders.&#xD;
&#xD;
          4. Patients under immunosuppressive drugs.&#xD;
&#xD;
          5. Patients under corticosteriods.&#xD;
&#xD;
          6. Patients with organ transplantation.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>25 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Mariam fakhr</last_name>
    <role>Study Chair</role>
    <affiliation>the Endocrine units at the Kasr Al-Ainy Cairo university hospital.</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Alaa Mahmoud Abd El Kader</name>
      <address>
        <city>Cairo</city>
        <zip>2020</zip>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <results_reference>
    <citation>Al-Maweri SA, Ismail NM, Ismail AR, Al-Ghashm A. Prevalence of oral mucosal lesions in patients with type 2 diabetes attending hospital universiti sains malaysia. Malays J Med Sci. 2013 Jul;20(4):39-46.</citation>
    <PMID>24043995</PMID>
  </results_reference>
  <results_reference>
    <citation>Bastos AS, Leite AR, Spin-Neto R, Nassar PO, Massucato EM, Orrico SR. Diabetes mellitus and oral mucosa alterations: prevalence and risk factors. Diabetes Res Clin Pract. 2011 Apr;92(1):100-5. doi: 10.1016/j.diabres.2011.01.011. Epub 2011 Mar 3.</citation>
    <PMID>21300417</PMID>
  </results_reference>
  <verification_date>January 2020</verification_date>
  <study_first_submitted>September 12, 2018</study_first_submitted>
  <study_first_submitted_qc>September 12, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">September 14, 2018</study_first_posted>
  <last_update_submitted>January 25, 2020</last_update_submitted>
  <last_update_submitted_qc>January 25, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">January 28, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Cairo University</investigator_affiliation>
    <investigator_full_name>Alaa Mahmoud abd El kader</investigator_full_name>
    <investigator_title>principle investigator, internal resident at oral medicine department</investigator_title>
  </responsible_party>
  <keyword>oral health status</keyword>
  <keyword>oral findings</keyword>
  <keyword>oral manifestations</keyword>
  <keyword>patients with diabetes</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Mouth Diseases</mesh_term>
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 2</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

